Abstract
Human amnion epithelial cells (hAECs), derived from discarded term placenta, is anticipated as a new stem cell resource because of their advantages over embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), such as no risk of tumorigenicity and minimal ethical issue. hAECs have been reported to differentiate into hepatic-like cells (HLCs) with variable functionalities suitable for cell-based therapy of end-stage liver diseases, drug screening, and drug toxicity tests. On the other hand, a new research stream has been evolving to use natural compounds as stimulants of stem cell differentiation because of their high availability and minimum side effects. Isorhamnetin is a naturally occurring flavonoid commonly found in fruits and vegetables and has been reported to improve hepatic fibrosis and steatosis. In this present study, we have screened the differentiation potential of isorhamnetin in hAECs. The cells were grown on 3D cell culture and were treated with 20 μM of synthesized isorhamnetin for 10 days without adding any additional growth factors. DNA microarray global gene expression analysis was conducted for differentially expressed genes between isorhamnetin-treated and untreated control cells, gene expression validation was carried out using RT-qPCR method, and finally, several hepatic functions were assessed. Microarray analysis showed that isorhamnetin could activate essential biological processes, molecular functions, and signaling pathways for hepatic differentiation. Hepatic progenitor markers, EPCAM and DLK1, were upregulated in the isorhamnetin-treated hAECs. AFP was downregulated, while ALB was upregulated on Day 10. Furthermore, isorhamnetin-treated cells could show increased CYP enzyme mRNA levels, ICG uptake and release, glycogen storage activity, and urea secretion. Additionally, isorhamnetin-treated cells did not show any trace of transdifferentiation evident by significant downregulation of several colon- and cholangiocyte-specific markers. However, longer treatment with isorhamnetin did not promote hepatic maturation. Altogether, our findings indicate that isorhamnetin has a promising effect on directing the hepatic-lineage specific differentiation in hAECs.
Highlights
IntroductionHuman amniotic epithelial cells (hAECs) are obtained from discarded term placenta, which is a medical waste product. hAECs are originated from the epiblast, retain pluripotent stem cell characteristics and give rise to all kinds of cells of three germ layers (Tamagawa et al, 2004; Miki et al, 2005; García-Castro et al, 2015)
Human amniotic epithelial cells are obtained from discarded term placenta, which is a medical waste product. hAECs are originated from the epiblast, retain pluripotent stem cell characteristics and give rise to all kinds of cells of three germ layers (Tamagawa et al, 2004; Miki et al, 2005; García-Castro et al, 2015)
We have investigated the early biological events regulated by isorhamnetin to induce hepatic-lineage-specific differentiation of hAECs maintained in 3D culture conditions through gene expression profiling and further validated several hepatic function tests
Summary
Human amniotic epithelial cells (hAECs) are obtained from discarded term placenta, which is a medical waste product. hAECs are originated from the epiblast, retain pluripotent stem cell characteristics and give rise to all kinds of cells of three germ layers (Tamagawa et al, 2004; Miki et al, 2005; García-Castro et al, 2015). Several studies have shown that upon appropriate differentiation protocol, hAECs can be differentiated into cardiomyocytes, pancreas and lung epithelium, bone and fat cells as well as neural cells (Miki et al, 2005, 2010; Toda et al, 2007; Parolini et al, 2008; Murphy et al, 2010; Fang et al, 2012). We have reported that the hAECs isolated from the adherent subpopulations of passaged primary cells have widely expressed stemness markers (Furuya et al, 2019). In 3D culture of hAECs, we could generate functional hepatic organoids using several growth factors (Furuya et al, 2019)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
